{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:46:23Z","timestamp":1778953583820,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1002\/jps.21555","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T17:53:17Z","timestamp":1220982797000},"page":"1788-1796","source":"Crossref","is-referenced-by-count":46,"title":["Trans-Ungual Iontophoretic Delivery of Terbinafine"],"prefix":"10.1016","volume":"98","author":[{"given":"Anroop B.","family":"Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva Ram K.","family":"Vaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa M.","family":"Sammeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip M.","family":"Friden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bireswar","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Narasimha Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21555_bb0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/17425247.3.1.127","article-title":"Transdermal iontophoresis","volume":"3","author":"Batheja","year":"2006","journal-title":"Expert Opin Drug Delivery"},{"key":"10.1002\/jps.21555_bb0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14728214.12.3.345","article-title":"Emerging therapeutic agents for onychomycosis","volume":"12","author":"Pierard","year":"2007","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1002\/jps.21555_bb0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-3083.2004.00988.x","article-title":"Topical antifungal drugs for the treatment of onychomycosis: An overview of current strategies for monotherapy and combination therapy","volume":"19","author":"Baran","year":"2005","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1002\/jps.21555_bb0020","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0926-9959(94)00073-9","article-title":"Therapeutic strategies in onychomycosis","volume":"4","author":"Effendy","year":"1995","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1002\/jps.21555_bb0025","first-page":"571","article-title":"Possible drug interactions in oral treatment of onychomycosis","volume":"87","author":"Katz","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/jps.21555_bb0030","first-page":"302","article-title":"The use of terbinafine in the treatment of onychomycosis in adults and special populations: A review of the evidence","volume":"4","author":"Gupta","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1002\/jps.21555_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200022010-00004","article-title":"A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis","volume":"22","author":"Gupta","year":"2000","journal-title":"Drug Safety"},{"key":"10.1002\/jps.21555_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21555_bb0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7547\/87507315-93-2-136","article-title":"Topical treatments for onychomycosis","volume":"93","author":"Bodman","year":"2003","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1002\/jps.21555_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1529-8019.2007.00109.x","article-title":"Toenail onychomycosis: Current and future treatment options","volume":"20","author":"Finch","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1002\/jps.21555_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00128071-200304010-00005","article-title":"Terbinafine: A review of its use in onychomycosis in adults","volume":"4","author":"Darkes","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1002\/jps.21555_bb0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2133.1990.tb01453.x","article-title":"Determination of terbinafine in nail samples during systemic treatment for onychomycoses","volume":"123","author":"Dykes","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1002\/jps.21555_bb0065","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/jps.20901","article-title":"In vitro penetration of novel oxaborole antifungal (AN2690) into the human nail plate","volume":"96","author":"Hui","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21555_bb0070","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/AAC.46.12.3797-3801.2002","article-title":"Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine","volume":"46","author":"Tatsumi","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21555_bb0075","first-page":"363","article-title":"Structural characteristics and permeability properties of the human nail: A review","volume":"50","author":"Gupchup","year":"1999","journal-title":"J Cosmet Sci"},{"key":"10.1002\/jps.21555_bb0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.2042-7158.1983.tb04258.x","article-title":"Physicochemical characterization of the human nail: Permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum","volume":"35","author":"Walters","year":"1983","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21555_bb0085","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.2042-7158.1985.tb04966.x","article-title":"Physicochemical characterization of the human nail: Solvent effects on the permeation of homologous alcohols","volume":"37","author":"Walters","year":"1985","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21555_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.2042-7158.1997.tb06747.x","article-title":"In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: Influence of the partition coefficient octanol\/water and the water solubility of drugs on their permeability and maximum flux","volume":"49","author":"Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21555_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jps.20757","article-title":"Iontophoretic drug delivery across human nail","volume":"96","author":"Murthy","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21555_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2006.12.010","article-title":"Iontophoretic permselective property of human nail","volume":"46","author":"Murthy","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1002\/jps.21555_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/000155557300304","article-title":"Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair, and nails during and after 250mg terbinafine orally once per day for four weeks","volume":"73","author":"Faergemann","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1002\/jps.21555_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2133.1994.tb06084.x","article-title":"Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses","volume":"130","author":"Clayton","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1002\/jps.21555_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1467-2494.2007.00372.x","article-title":"Nail biology and nail science","volume":"29","author":"deBerker","year":"2007","journal-title":"Int J Cosmetic Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916329586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916329586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T18:02:47Z","timestamp":1709229767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916329586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0022354916329586"],"URL":"https:\/\/doi.org\/10.1002\/jps.21555","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}